Callaway, Kari
Elan Pharmaceuticals, Inc. (Ireland)
4 papers on CoChat
Most cited papers
- Verified
Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
Tóth, G., Gardai, S. J., Zago, W., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · PLoS ONE
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 151
- Verified
Proximity-Induced Catalysis by the Protein Kinase ERK2
Rainey, M. A., Callaway, K., Barnes, R., Wilson, B., & Dalby, K. N. (2005) · Journal of the American Chemical Society
Protein Kinase Regulation and GTPase SignalingProtein Structure and Dynamics
Cited by 52
- Verified
Phosphorylation of the Transcription Factor Ets-1 by ERK2: Rapid Dissociation of ADP and Phospho-Ets-1
Callaway, K., Waas, W. F., Rainey, M. A., Ren, P., & Dalby, K. N. (2010) · Biochemistry
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 32
- Verified
Quantifying ERK2–protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains
Callaway, K., Rainey, M. A., & Dalby, K. N. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free